Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Barrington, David A
409  Ergebnisse:
Personensuche X
?
1

Retraction notice to "Cost-effectiveness of chemotherapy an..:

Riedinger, Courtney J. ; Barrington, David A. ; Nagel, Christa I....
Gynecologic Oncology.  183 (2024)  - p. R1 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Learning to lead: The evolution of a pilot leadership curri..:

Levine, Monica D. ; Wagner, Vincent M. ; Riedinger, Courtney J....
Gynecologic Oncology Reports.  52 (2024)  - p. 101327 , 2024
Link: https://doi.org/10.1016/..
 
?
3

RETRACTED: Cost-effectiveness of chemotherapy and dostarlim..:

Riedinger, Courtney J. ; Barrington, David A. ; Nagel, Christa I....
Gynecologic Oncology.  183 (2024)  - p. 78-84 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Assessment of the feasibility of same-day discharge followi..:

Haight, Paulina J ; Piver, Rachael N ; Barrington, David A...
Gynecologic Oncology Reports.  48 (2023)  - p. 101227 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Safety and feasibility of same-day discharge following mini..:

Haight, Paulina J. ; Barrington, David A. ; Graves, Stephen M....
Gynecologic Oncology.  170 (2023)  - p. 203-209 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Glassy cell carcinoma of the cervix: Findings from a combin..:

Levine, Monica D. ; Barrington, David A. ; Meade, Caitlin E....
Gynecologic Oncology.  173 (2023)  - p. 15-21 , 2023
Link: https://doi.org/10.1016/..
 
?
7

High pre-treatment neutrophil-to-lymphocyte ratio as a prog..:

Calo, Corinne A. ; Barrington, David A. ; Brown, Morgan...
Gynecologic Oncology Reports.  42 (2022)  - p. 101040 , 2022
Link: https://doi.org/10.1016/..
 
?
8

P3 Less is more: abdominal closure protocol does not reduce..:

Boyles, Glenn ; DeMari, Joseph ; Barrington, David...
Gynecologic Oncology.  165 (2022)  - p. S6 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Equity vs. variety: Demographic and facility factors are as..:

Barrington, David ; Levine, Monica ; Meade, Caitlin..
Gynecologic Oncology.  166 (2022)  - p. S110-S111 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Racial and ethnic disparities in readmission risk following..:

Barrington, David A. ; Meade, Caitlin E. ; Cosgrove, Casey M...
Gynecologic Oncology.  166 (2022)  3 - p. 543-551 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Does the addition of radiation improve survival compared to..:

Barrington, David A. ; Fox, Brandon ; Meade, Caitlin...
Gynecologic Oncology.  165 (2022)  3 - p. 522-529 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Pembrolizumab for persistent, recurrent, or metastatic cerv..:

Barrington, David ; Riedinger, Courtney ; Haight, Paulina..
Gynecologic Oncology.  166 (2022)  - p. S19 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Implementing universal upfront multi-gene panel testing in ..:

Levine, Monica D. ; Barrington, David A. ; Hampel, Heather..
Gynecologic Oncology.  166 (2022)  3 - p. 538-542 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Pembrolizumab with or without bevacizumab for recurrent or ..:

Barrington, David A. ; Riedinger, Courtney ; Haight, Paulina J...
Gynecologic Oncology.  165 (2022)  3 - p. 500-505 , 2022
Link: https://doi.org/10.1016/..
 
?
15

O2 Beyond mismatch repair deficiency? Pre-treatment neutrop..:

Baek, Jae ; Brown, Morgan ; Barrington, David...
Gynecologic Oncology.  165 (2022)  - p. S1-S2 , 2022
Link: https://doi.org/10.1016/..
 
1-15